Amlodipine inhibition of alpha-agonist induced contraction in human resistance vessels.
Garcha
R
R
Department of Clinical Pharmacology, St Mary's Hospital, London, UK.
Schachter
M
M
Hughes
A
A
Thom
S M
SM
Sever
P
P
D000316:Adrenergic alpha-Agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D017311:Amlodipine; D001381:Azepines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010656:Phenylephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012867:Skin / Q000098:blood supply; D014661:Vasoconstriction / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D001381:Azepines; D002121:Calcium Channel Blockers; D017311:Amlodipine; D010656:Phenylephrine; C015603:azepexole; D009543:Nifedipine; D009638:Norepinephrine